BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35538298)

  • 1. Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.
    Keegan NM; Vasselman SE; Barnett ES; Nweji B; Carbone EA; Blum A; Morris MJ; Rathkopf DE; Slovin SF; Danila DC; Autio KA; Scher HI; Kantoff PW; Abida W; Stopsack KH
    Prostate; 2022 Aug; 82(11):1107-1116. PubMed ID: 35538298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracting data from electronic medical records: validation of a natural language processing program to assess prostate biopsy results.
    Thomas AA; Zheng C; Jung H; Chang A; Kim B; Gelfond J; Slezak J; Porter K; Jacobsen SJ; Chien GW
    World J Urol; 2014 Feb; 32(1):99-103. PubMed ID: 23417341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of data quality in the National Prostate Cancer Register of Sweden.
    Tomic K; Sandin F; Wigertz A; Robinson D; Lambe M; Stattin P
    Eur J Cancer; 2015 Jan; 51(1):101-11. PubMed ID: 25465187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hybrid solution for extracting structured medical information from unstructured data in medical records via a double-reading/entry system.
    Luo L; Li L; Hu J; Wang X; Hou B; Zhang T; Zhao LP
    BMC Med Inform Decis Mak; 2016 Aug; 16(1):114. PubMed ID: 27577240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for harmonized structured documentation and chances of secondary use - results of a systematic analysis with automated form comparison for prostate and breast cancer.
    Krumm R; Semjonow A; Tio J; Duhme H; Bürkle T; Haier J; Dugas M; Breil B
    J Biomed Inform; 2014 Oct; 51():86-99. PubMed ID: 24747879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
    Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
    Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Historical prostate cancer screening and treatment outcomes from a single institution.
    Cross DS; Ritter M; Reding DJ
    Clin Med Res; 2012 Aug; 10(3):97-105. PubMed ID: 22537761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.
    Sutcliffe P; Connock M; Shyangdan D; Court R; Kandala NB; Clarke A
    Health Technol Assess; 2013 Sep; 17(42):1-274. PubMed ID: 24070110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer: what about reproducibility of decision made at multidisciplinary team management?
    Bayoud Y; Loock PY; Messaoudi R; Ripert T; Pierrevelcin J; Kozal S; Leon P; Kamdoum M; Irène C; Menard J
    Urol J; 2015 Apr; 12(2):2078-82. PubMed ID: 25923152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease and Treatment Characteristics of Men Diagnosed With Metastatic Hormone-Sensitive Prostate Cancer in Real Life: Analysis From a Commercial Claims Database.
    Flaig TW; Potluri RC; Ng Y; Todd MB; Mehra M; Higano CS
    Clin Genitourin Cancer; 2017 Apr; 15(2):273-279.e1. PubMed ID: 27876504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
    Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
    Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of electronic data on chemotherapy and hormone therapy use in HMOs.
    Ritzwoller DP; Carroll N; Delate T; O'Keeffe-Rossetti M; Fishman PA; Loggers ET; Aiello Bowles EJ; Elston-Lafata J; Hornbrook MC
    Med Care; 2013 Oct; 51(10):e67-73. PubMed ID: 22531648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer.
    Eminaga O; Abbas M; Hinkelammert R; Titze U; Bettendorf O; Eltze E; Ozgür E; Semjonow A
    BMC Med Inform Decis Mak; 2012 Dec; 12():141. PubMed ID: 23206574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
    Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
    Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.